Epirubicin hydrochloride CAS: 56390-09-1

CAS NO: 56390-09-1
Epirubicin hydrochloride
Chemical Name: Epirubicin hydrochloride
Molecular Formula: C27H30ClNO11
Formula Weight: 579.9802
CAS No.: 56390-09-1
Description Review
Description

Epirubicin hydrochloride is a medication that is used in the treatment of cancer. The medication is also known as epirubicin HCL, and its chemical name is 7S, 9R)-9-acetyl-7-[(2R, 4S, 5S, 6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6, 9, 11-trihydroxy-8, 10-dihydro-7H-tetracene-5, 12-dione hydrochloride. It has a molecular formula of C27H30ClNO11 and a formula weight of 579.98 grams per mole. The substance is also known by other names, including Epi, Ellence, and Pharmorubicin.

Top ten keywords from Google:

  1. Epirubicin hydrochloride cancer
  2. Epirubicin hydrochloride mechanism of action
  3. Epirubicin hydrochloride side effects
  4. Epirubicin hydrochloride dosage
  5. Epirubicin hydrochloride injection
  6. Epirubicin hydrochloride oral
  7. Epirubicin hydrochloride chemotherapy
  8. Epirubicin hydrochloride molecular weight
  9. Epirubicin hydrochloride synthesis
  10. Epirubicin hydrochloride pharmacokinetics

Synonyms:

Here are some synonyms for Epirubicin hydrochloride:

  1. (7S,9R)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
  2. C27H30ClNO11 HCI
  3. (1S,2S,4R,8S,10S,11S,12S,13R)-8-acetyl-1,5,12-trihydroxy-13-((2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydropyran-2-yloxy)-6,11-dihydroxy-2,4,7,10-tetrahydrotetracene-9,14-dione hydrochloride
  4. EPI
  5. Ellence
  6. Pharmorubicin

Health Benefits of This Product:

Epirubicin hydrochloride is used in the treatment of different types of cancer, including breast cancer, bladder cancer, and stomach cancer. It prevents cancer cells from multiplying by interfering with the replication of DNA, and thereby slowing down the growth of cancer cells. In some cases, it also induces apoptosis, leading to the death of cancer cells.

Potential Effects:

Epirubicin hydrochloride is a highly effective medication for different types of cancers. It is used in combination with other drugs and radiation for the treatment of breast cancer, bladder cancer, and stomach cancer. The medication is highly potent and effective in destroying cancer cells. However, there are some side effects associated with the use of epirubicin hydrochloride, which should be considered before using it.

Product Mechanism:

Epirubicin hydrochloride works through an intercalation mechanism, where the medication intercalates between base pairs in the DNA strand, thus causing errors in DNA replication. The drug also reacts with topoisomerase II, leading to single-strand breaks, double-strand breaks, and DNA-protein crosslinking, which results in cell death.

Safety:

Epirubicin hydrochloride is a highly potent medication that is considered safe when used correctly. Patients should be aware of the potential side effects, which may include nausea, vomiting, fatigue, hair loss, and diarrhea. In some cases, the medication may cause more serious side effects, such as anemia or neutropenia, which should be monitored.

Side Effects:

The side effects of epirubicin hydrochloride vary from patient to patient, but common side effects include nausea, vomiting, hair loss, fatigue, and diarrhea. Other potential side effects include anemia, infections, and neutropenia. If the side effects become severe, treatment may need to be adjusted.

Dosing Information:

The dosing of epirubicin hydrochloride depends on the type of cancer being treated, the patient's age, and their overall health. The medication is typically given through an intravenous infusion or injection. The dosage is usually calculated based on the patient's body surface area, and the treatment is typically given as a cycle of several doses over several weeks.

Conclusion:

Epirubicin hydrochloride is a highly effective medication for the treatment of different types of cancers. The medication works by interfering with DNA replication and inducing cell death. The drug is a potent chemotherapy agent and is typically used in combination with other treatments, including radiation and surgery. The medication has some potential side effects, and patients should be aware of these before starting treatment. Overall, the medication has proven to be a valuable tool in the treatment of cancer and has improved the outlook for patients with this disease.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code